Investigational medical product (IMP) administered in parent study
Sponsors
Pfizer
Conditions
Cancer PainOsteoarthritisRecurrent Low Back Pain
Phase 3
Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
CompletedNCT02674386
Start: 2016-08-23End: 2019-07-15Updated: 2020-07-30
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies
CompletedNCT03031938
Start: 2017-11-03End: 2020-06-04Updated: 2021-06-25